Nynomic Balance Sheet Health

Financial Health criteria checks 6/6

Nynomic has a total shareholder equity of €105.8M and total debt of €7.5M, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are €146.4M and €40.6M respectively. Nynomic's EBIT is €14.7M making its interest coverage ratio 18.7. It has cash and short-term investments of €15.4M.

Key information

7.1%

Debt to equity ratio

€7.48m

Debt

Interest coverage ratio18.7x
Cash€15.41m
Equity€105.79m
Total liabilities€40.58m
Total assets€146.37m

Recent financial health updates

Recent updates

One Nynomic AG (ETR:M7U) Analyst Just Made A Major Cut To Next Year's Estimates

Oct 11
One Nynomic AG (ETR:M7U) Analyst Just Made A Major Cut To Next Year's Estimates

Is Nynomic AG (ETR:M7U) Potentially Undervalued?

Oct 09
Is Nynomic AG (ETR:M7U) Potentially Undervalued?

Nynomic's (ETR:M7U) Earnings Are Of Questionable Quality

May 30
Nynomic's (ETR:M7U) Earnings Are Of Questionable Quality

Is It Too Late To Consider Buying Nynomic AG (ETR:M7U)?

Mar 21
Is It Too Late To Consider Buying Nynomic AG (ETR:M7U)?

Is There Now An Opportunity In Nynomic AG (ETR:M7U)?

Nov 20
Is There Now An Opportunity In Nynomic AG (ETR:M7U)?

Is Nynomic AG (ETR:M7U) Trading At A 39% Discount?

Nov 22
Is Nynomic AG (ETR:M7U) Trading At A 39% Discount?

When Should You Buy Nynomic AG (ETR:M7U)?

Oct 26
When Should You Buy Nynomic AG (ETR:M7U)?

Returns On Capital At Nynomic (ETR:M7U) Paint A Concerning Picture

Oct 11
Returns On Capital At Nynomic (ETR:M7U) Paint A Concerning Picture

Nynomic (ETR:M7U) Has A Pretty Healthy Balance Sheet

Sep 13
Nynomic (ETR:M7U) Has A Pretty Healthy Balance Sheet

Should You Think About Buying Nynomic AG (ETR:M7U) Now?

Jul 12
Should You Think About Buying Nynomic AG (ETR:M7U) Now?

Nynomic (ETR:M7U) Will Be Hoping To Turn Its Returns On Capital Around

Feb 23
Nynomic (ETR:M7U) Will Be Hoping To Turn Its Returns On Capital Around

Should You Think About Buying Nynomic AG (ETR:M7U) Now?

Jan 10
Should You Think About Buying Nynomic AG (ETR:M7U) Now?

These 4 Measures Indicate That Nynomic (ETR:M7U) Is Using Debt Reasonably Well

Jun 01
These 4 Measures Indicate That Nynomic (ETR:M7U) Is Using Debt Reasonably Well

Is Now An Opportune Moment To Examine Nynomic AG (ETR:M7U)?

May 17
Is Now An Opportune Moment To Examine Nynomic AG (ETR:M7U)?

Returns On Capital Signal Tricky Times Ahead For Nynomic (ETR:M7U)

Apr 12
Returns On Capital Signal Tricky Times Ahead For Nynomic (ETR:M7U)

Calculating The Intrinsic Value Of Nynomic AG (ETR:M7U)

Mar 08
Calculating The Intrinsic Value Of Nynomic AG (ETR:M7U)

What Does Nynomic AG's (ETR:M7U) Share Price Indicate?

Feb 09
What Does Nynomic AG's (ETR:M7U) Share Price Indicate?

Are Robust Financials Driving The Recent Rally In Nynomic AG's (ETR:M7U) Stock?

Jan 25
Are Robust Financials Driving The Recent Rally In Nynomic AG's (ETR:M7U) Stock?

Has Nynomic (ETR:M7U) Got What It Takes To Become A Multi-Bagger?

Jan 06
Has Nynomic (ETR:M7U) Got What It Takes To Become A Multi-Bagger?

Nynomic (ETR:M7U) Shareholders Have Enjoyed A Whopping 497% Share Price Gain

Dec 22
Nynomic (ETR:M7U) Shareholders Have Enjoyed A Whopping 497% Share Price Gain

Calculating The Intrinsic Value Of Nynomic AG (ETR:M7U)

Dec 07
Calculating The Intrinsic Value Of Nynomic AG (ETR:M7U)

Does Nynomic's (ETR:M7U) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does Nynomic's (ETR:M7U) Statutory Profit Adequately Reflect Its Underlying Profit?

Financial Position Analysis

Short Term Liabilities: M7U's short term assets (€72.2M) exceed its short term liabilities (€23.4M).

Long Term Liabilities: M7U's short term assets (€72.2M) exceed its long term liabilities (€17.2M).


Debt to Equity History and Analysis

Debt Level: M7U has more cash than its total debt.

Reducing Debt: M7U's debt to equity ratio has reduced from 60.5% to 7.1% over the past 5 years.

Debt Coverage: M7U's debt is well covered by operating cash flow (166.8%).

Interest Coverage: M7U's interest payments on its debt are well covered by EBIT (18.7x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/17 04:08
End of Day Share Price 2024/12/17 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nynomic AG is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrick SpeckMontega AG
Bastian BrachMontega AG
Pierre GröningMontega AG